These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15211864)

  • 21. Variation in Bordetella pertussis Susceptibility to Erythromycin and Virulence-Related Genotype Changes in China (1970-2014).
    Yang Y; Yao K; Ma X; Shi W; Yuan L; Yang Y
    PLoS One; 2015; 10(9):e0138941. PubMed ID: 26406905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevalence of pertussis in Fukuoka: incidence and MICs of antibiotics for Bordetella pertussis isolate].
    Horikawa K; Okada K; Ishibashi T; Murakami K; Ohbuchi N; Ueda K
    Kansenshogaku Zasshi; 1995 Aug; 69(8):878-83. PubMed ID: 7594779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surveillance of antimicrobial resistance in contemporary clinical isolates of Bordetella pertussis in Ontario, Canada.
    Marchand-Austin A; Memari N; Patel SN; Tang P; Deeks SL; Jamieson FB; Crowcroft NS; Farrell DJ
    Int J Antimicrob Agents; 2014 Jul; 44(1):82-4. PubMed ID: 24837412
    [No Abstract]   [Full Text] [Related]  

  • 24. The comparative in-vitro activity of roxithromycin and other antibiotics against Bordetella pertussis.
    Brett M; Short P; Beatson S
    J Antimicrob Chemother; 1998 Mar; 41 Suppl B():23-7. PubMed ID: 9579709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recovery of Bordetella holmesii from patients with pertussis-like symptoms: use of pulsed-field gel electrophoresis to characterize circulating strains.
    Mazengia E; Silva EA; Peppe JA; Timperi R; George H
    J Clin Microbiol; 2000 Jun; 38(6):2330-3. PubMed ID: 10834997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial susceptibility testing of clinical isolates of Bordetella pertussis from northern California: report from the SENTRY Antimicrobial Surveillance Program.
    Gordon KA; Fusco J; Biedenbach DJ; Pfaller MA; Jones RN
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3599-600. PubMed ID: 11709347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimum inhibitory concentrations of erythromycin and other antibiotics for Czech strains of Bordetella pertussis.
    Jakubů V; Zavadilová J; Fabiánová K; Urbášková P
    Epidemiol Mikrobiol Imunol; 2015 Mar; 64(1):12-5. PubMed ID: 25872990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative DNA analysis of Bordetella pertussis clinical isolates by pulsed-field gel electrophoresis, randomly amplified polymorphism DNA, and ERIC polymerase chain reaction.
    Moissenet D; Valcin M; Marchand V; Grimprel E; Bégué P; Garbarg-Chenon A; Vu-Thien H
    FEMS Microbiol Lett; 1996 Oct; 143(2-3):127-32. PubMed ID: 8837464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity and clinical efficacy of macrolides, cefoperazone-sulbactam and piperacillin/piperacillin-tazobactam against Bordetella pertussis and the clinical manifestations in pertussis patients due to these isolates: A single-centre study in Zhejiang Province, China.
    Hua CZ; Wang HJ; Zhang Z; Tao XF; Li JP; Mi YM; Tang LF; Chen ZM
    J Glob Antimicrob Resist; 2019 Sep; 18():47-51. PubMed ID: 30710647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The global prevalence ptxP3 lineage of Bordetella pertussis was rare in young children with the co-purified aPV vaccination: a 5 years retrospective study.
    Wang Z; Luan Y; Du Q; Shu C; Peng X; Wei H; Hou T; Liu Y; Liu X; Li Y
    BMC Infect Dis; 2020 Aug; 20(1):615. PubMed ID: 32814558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bordetella pertussis isolates with a heterogeneous phenotype for erythromycin resistance.
    Wilson KE; Cassiday PK; Popovic T; Sanden GN
    J Clin Microbiol; 2002 Aug; 40(8):2942-4. PubMed ID: 12149356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Swedish Bordetella pertussis isolates with three typing methods: characterization of an epidemic lineage.
    Advani A; Van der Heide HG; Hallander HO; Mooi FR
    J Microbiol Methods; 2009 Sep; 78(3):297-301. PubMed ID: 19577594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulsed-field gel electrophoresis characterization of Bordetella pertussis clinical isolates circulating in Turkey in 2001-2009.
    Nar Otgun S; Durmaz R; Karagoz A; Esen B; Ertek M
    Eur J Clin Microbiol Infect Dis; 2011 Oct; 30(10):1229-36. PubMed ID: 21461658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for transmission of pertussis in schools, Massachusetts, 1996: epidemiologic data supported by pulsed-field gel electrophoresis studies.
    Brennan M; Strebel P; George H; Yih WK; Tachdjian R; Lett SM; Cassiday P; Sanden G; Wharton M
    J Infect Dis; 2000 Jan; 181(1):210-5. PubMed ID: 10608769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical manifestations of children with microbiologically confirmed pertussis infection and antimicrobial susceptibility of isolated strains in a regional hospital in Japan, 2008-2012.
    Horiba K; Nishimura N; Gotoh K; Kawaguchi M; Takeuchi S; Hattori F; Isaji M; Okai Y; Hosono H; Takemoto K; Ozaki T
    Jpn J Infect Dis; 2014; 67(5):345-8. PubMed ID: 25241683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial susceptibilities of Bordetella species isolated in a Multicenter Pertussis Surveillance Project.
    Kurzynski TA; Boehm DM; Rott-Petri JA; Schell RF; Allison PE
    Antimicrob Agents Chemother; 1988 Jan; 32(1):137-40. PubMed ID: 2894817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999.
    Hardwick TH; Cassiday P; Weyant RS; Bisgard KM; Sanden GN
    Emerg Infect Dis; 2002 Jan; 8(1):44-9. PubMed ID: 11749747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in Predominance of Pulsed-Field Gel Electrophoresis Profiles of Bordetella pertussis Isolates, United States, 2000-2012.
    Cassiday PK; Skoff TH; Jawahir S; Tondella ML
    Emerg Infect Dis; 2016 Mar; 22(3):442-8. PubMed ID: 26886905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Manifestations and Molecular Characterization of Pertactin-Deficient and Pertactin-Producing Bordetella pertussis in Children, Philadelphia 2007-2014.
    Vodzak J; Queenan AM; Souder E; Evangelista AT; Long SS
    Clin Infect Dis; 2017 Jan; 64(1):60-66. PubMed ID: 27624959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.
    Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D
    Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.